期刊文献+

倍他乐克治疗慢性心力衰竭的临床研究 被引量:5

下载PDF
导出
摘要 目的观察倍他乐克治疗慢性心力衰竭的临床疗效。方法对55例慢性心力衰竭患者,随机分为治疗组28例,在常规治疗基础上予以倍他乐克口服,常规治疗组27例,予以常规治疗。结果两组治疗前后心功能改善及餐后心率差异有显著性(P<0.05);静卧心率及室性期前收缩发生率两组治疗前后无差异性(P>0.05)。结论倍他乐克治疗慢性心力衰竭的疗效明显,安全性好。
作者 郑海波
出处 《安徽医药》 CAS 2007年第6期505-506,共2页 Anhui Medical and Pharmaceutical Journal
  • 相关文献

参考文献5

二级参考文献13

  • 1沈剑清.特发性扩张型心肌病的β肾上腺素受体调节和左室功能[J].国外医学(心血管疾病分册),1994,21(1):22-24. 被引量:19
  • 2袁志敏,吕渠霞.心力衰竭的现代观点与诊治进展[J].心血管病学进展,1994,15(3):149-153. 被引量:52
  • 3李德之.心力衰竭时β-阻滞剂应用的原则与经验[J].中国实用内科杂志,1994,14(2):75-76. 被引量:70
  • 4Bristow MR. What type of beta-blocker should be used to treat chronic heart failure? Circulation, 2000, 10:484-486.
  • 5De Mey C. Inverse PK/PD: estimation and differentiation of bioavailability from effect kinetics-observations with beta-adrenoceptor antagonists. Int J Clin Pharmacol Ther, 1997, 35: 453-457.
  • 6Vanhees L, Aubert A, Fagard R, et al. Influence of beta 1- versus beta 2-adrenoceptor blockade on left ventricular function in humans. J Cardiovasc Pharmacol, 1986, 8: 1086-1091.
  • 7De Mey C, Breithaupt-Grogler K, Schloos J, et al. Reproducibility and consistency of the responses to supine bicycle ergometry; evaluation in conjunction with beta 1-adrenoceptor occupancies. Br J Clin Pharmacol, 1994, 38: 480-483.
  • 8Packer M. Do β-blockers prolong survival in heart failure only by inhibiting the β1-receptor? A perspective on the results of the COMET trial. J Card Fail, 2003, 9:429-443.
  • 9Kukin ML, Mannino MM, Freudenberger RS, et al. Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure. J Am Coll Cardiol, 2000, 35: 45-50.
  • 10Sandberg A, Abrahamsson B, Svenheden A, et al. Steady-state bioavailability and day-to-day variability of a multiple-unit (CR/ZOK) and a single-unit (OROS) delivery system of metoprolol after once-daily dosing. Pharm Res, 1993, 10:28-34.

共引文献160

同被引文献52

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部